Welcome : Guest

Protalex, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Protalex, Inc., which is principally involved in the Development of a Class of Biopharmaceutical Drugs. Illustrated with 12 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-19487
Price: $600
Company Type: Public
Pages: 13
Date: November 2016
Market Data Tables: 12

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Biopharmaceuticals......2
Table 1: Biopharmaceuticals Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Norditropin, NovoSeven, Turoctocog Alpha, and Others......2
Speciality Pharmaceuticals......3
Table 2: Speciality Pharmaceuticals Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Anti-Coagulant, Growth Hormone, Hepatitis C, HIV/AIDS (incl oral solids), IVIG/Hemophilia, Macular Degeneration, Multiple Sclerosis, Oncology (incl. oral solids), Pulmonary Arterial Hypertension, Renal, Rheumatoid arthritis/Chrohn's, Transplant, and Others......3
Table 3: Specialty Inflammatory Conditions Drugs Benefit Market by Category in the US (2015) - Percentage Share Breakdown by Value for Medical Benefit and Pharmacy Benefit......4
Table 4: Specialty Pharmaceuticals Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Hepatitis, HIV & AIDS (including oral solids), Intravenous Immunoglobulin (Hemophilia), Multiple Sclerosis, Oncology (including oral solids), Renal, Rheumatoid Arthritis (Crohn's), and Others......5
Rheumatoid Arthritis......6
Table 5: Rheumatoid Arthritis Market by Product Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for ENBREL, HUMIRA, REMICADE, and Others......6
Arthritis and Rheumatics......7
Table 6: Arthritis and Rheumatic Statistics in the US......7
Biologics......8
Table 7: No. of Biologics in Development by Therapeutic Area Worldwide (2015) - Percentage Market Share Breakdown for Autoimmune Disorders, Blood Disorders, Cancer/ Related Conditions, Cardiovascular Disease, Diabetes/Related Conditions, Digestive Disorders, Eye Conditions, Genetic Disorders, Infectious Diseases, Musculoskeletal Disorders, Neurologic Disorders, Respiratory Disorders, Skin Diseases, Transplantation, and Others......8
Autoimmune Diseases......9
Table 8: Therapeutic Classes Market by Segment in the US (2015) – Percentage Market Share Breakdown by Value Sales for Antidiabetics, Antihypertensives, Autoimmune Diseases, HIV Antivirals, Lipid Regulators, Mental Health, Oncologics, Pain, Respiratory Agents, and Others......9
Biopharmaceuticals......10
Table 9: Market Shares of Leading Biopharmaceutical Companies Worldwide (2014) - Percentage Breakdown by Volume (Installed Capacity) for Amgen Inc., Biogen Idec, Inc., Bristol-Myers Squibb Company, C.H. Boehringer Sohn AG & Co. KG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson Ltd., Lonza Group Ltd., Pfizer, Inc., Sanofi S.A., and Others......10
Table 10: Market Shares of Leading Biopharmaceutical Companies in the US (2015) - Percentage Market Share Breakdown by Value for Actelion Pharmaceuticals Ltd., Alexion Pharmaceuticals, Inc., Celgene Corporation, Gilead Sciences, Inc., Incyte, Corporation, Isis Pharmaceuticals, Inc., Vertex Pharmaceuticals, Inc., and Others......11
Anti-Inflammatory Biologics......12
Table 11: Market Shares of Leading Anti-Inflammatory Biologic Brands Worldwide (2015) - Percentage Share Breakdown by Value for Actemra, Enbrel, Humira, Remicade and Other......12
Treatment of Chemotherapy-Induced Thrombocytopenia (CIT)......13
Table 12: Market Shares of Leading Drugs for the Treatment of Chemotherapy-Induced Thrombocytopenia (CIT) in China (2015) - Percentage Share Breakdown by Value for Baijieyi, Juheli, Recombinant Human Thrombopoietin, Te Er Kang and Others......13